Renaissance Technologies’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-256,350
Closed -$956K 4020
2024
Q3
$956K Buy
256,350
+12,100
+5% +$45.1K ﹤0.01% 2472
2024
Q2
$1.37M Sell
244,250
-89,600
-27% -$502K ﹤0.01% 2131
2024
Q1
$1.75M Buy
333,850
+39,400
+13% +$206K ﹤0.01% 2120
2023
Q4
$1.54M Buy
294,450
+38,298
+15% +$200K ﹤0.01% 2108
2023
Q3
$4.04M Sell
256,152
-4,321
-2% -$68.2K 0.01% 1426
2023
Q2
$5.06M Buy
260,473
+51,623
+25% +$1M 0.01% 1425
2023
Q1
$5.93M Sell
208,850
-57,800
-22% -$1.64M 0.01% 1376
2022
Q4
$7.79M Sell
266,650
-7,629
-3% -$223K 0.01% 1243
2022
Q3
$7.25M Buy
274,279
+21,300
+8% +$563K 0.01% 1210
2022
Q2
$11.2M Buy
252,979
+39,400
+18% +$1.75M 0.01% 1045
2022
Q1
$10.6M Buy
213,579
+5,800
+3% +$287K 0.01% 1092
2021
Q4
$10.6M Buy
207,779
+5,500
+3% +$280K 0.01% 1037
2021
Q3
$11.3M Buy
202,279
+5,400
+3% +$301K 0.01% 957
2021
Q2
$8.43M Sell
196,879
-7,800
-4% -$334K 0.01% 1301
2021
Q1
$8.54M Sell
204,679
-22,500
-10% -$939K 0.01% 1292
2020
Q4
$10.6M Sell
227,179
-58,821
-21% -$2.74M 0.01% 1123
2020
Q3
$12.1M Sell
286,000
-63,500
-18% -$2.7M 0.01% 1016
2020
Q2
$16.8M Buy
349,500
+60,900
+21% +$2.92M 0.01% 927
2020
Q1
$13.3M Buy
288,600
+131,900
+84% +$6.07M 0.01% 990
2019
Q4
$9.42M Buy
156,700
+120,400
+332% +$7.23M 0.01% 1488
2019
Q3
$2.05M Buy
+36,300
New +$2.05M ﹤0.01% 2270
2015
Q3
Sell
-23,400
Closed -$1.89M 3410
2015
Q2
$1.89M Sell
23,400
-36,500
-61% -$2.95M ﹤0.01% 2099
2015
Q1
$2.51M Buy
+59,900
New +$2.51M 0.01% 1803